Clinical Trials for Advanced Solid Tumor

Find clinical trials for advanced solid tumor. Discover research opportunities and treatment options in your area.

358 Active Trials Found

Showing 358 trials on this page

Page 17 of 18

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

NCT ID: NCT05148325

This clinical trial is testing a new treatment called BAT4706 for patients with advanced solid tumors, including melanoma. The main goal is to find out if BAT4706 is safe, how well it is tolerated ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China, Beijing, Beijing, China

A Study of QLF3108 in Participants With Advanced Solid Tumor

NCT ID: NCT06019013

This clinical trial is studying a new medication called QLF3108 to see how safe it is and how well it works against advanced solid tumors, which are types of cancer that form in different organs. R...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

NCT ID: NCT06006793

This clinical trial is studying a new treatment called SY-5933 for patients with advanced solid tumors that have a specific genetic mutation known as KRAS p.G12C. The goal is to learn more about ho...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China, Shanghai, , China

A Study to Investigate FP002 in Subjects With Advanced Malignancies

NCT ID: NCT05982080

This clinical trial is studying a new treatment called FP002 for patients with advanced solid tumors, which are types of cancer that have spread and no longer respond to standard therapies. The mai...

Recruiting

Phase: PHASE1 Type: interventional Locations: Xiamen, Fujian, China, Linyi, Shangdong, China +1 more

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

NCT ID: NCT05420545

This clinical trial is studying a new treatment called CD70-targeted CAR-T therapy for patients with advanced or metastatic solid tumors that express a protein called CD70. This includes cancers su...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

NCT ID: NCT05468190

This clinical trial is studying a new treatment approach for patients with certain types of advanced or metastatic solid tumors, including renal cell carcinoma, ovarian cancer, and cervical cancer....

Recruiting

Phase: PHASE1 Type: interventional Locations: Zhengzhou, Henan, China

A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

NCT ID: NCT06001580

This clinical trial is studying a new treatment called BR101, specifically for patients with advanced solid tumors, which are types of cancer that have spread beyond their original site and cannot ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors

NCT ID: NCT05840835

This clinical trial is looking at a new treatment combination for patients with advanced solid tumors, which are types of cancer that form masses in organs or tissues. The study is testing a drug c...

Recruiting

Phase: PHASE1 Type: interventional Locations: São Paulo, Sao Paulo, Brazil, Santo André, São Paulo, Brazil +2 more

MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.

NCT ID: NCT05888857

This clinical trial, called MEDI5752, is looking into a new treatment for patients with advanced solid tumors, which are types of cancer that form in tissues like organs, muscles, or bone. The stud...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Bordeaux, , France

Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

NCT ID: NCT05884801

This clinical trial is testing a new treatment called QLS1103 for patients with advanced solid tumors, which are types of cancer that form in organs or tissues. It is a Phase I study, meaning it is...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer

NCT ID: NCT05491083

This clinical trial is testing a new treatment for patients with advanced solid tumors, particularly focusing on those with triple-negative breast cancer (TNBC). The study is exploring the safety a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Singapore, , Singapore

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

NCT ID: NCT05944185

This clinical trial is studying a new treatment involving a type of immune cell called CAR T cells, specifically designed to target certain advanced solid tumors that express a protein called MSLN....

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors

NCT ID: NCT05924906

This clinical trial is studying a new treatment called NB002 for patients with advanced solid tumors that have not responded to standard therapies. It's a first-time study in humans, focusing on un...

Not yet recruiting

Phase: PHASE1 Type: interventional

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor

NCT ID: NCT05933668

This clinical trial is studying a new treatment called YK0901, which is an immunotherapy designed specifically for patients with advanced solid tumors that have a particular genetic mutation known ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors

NCT ID: NCT05911464

This clinical trial, called a Phase I study, is looking at a new treatment called HS-10386 for people with advanced solid tumors that have not responded to previous therapies. The main goal is to s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

NCT ID: NCT05780307

This clinical trial, called IMM2520, is testing a new treatment for patients with advanced solid tumors, including lung, breast, and colorectal cancers. The main goal is to see how safe the treatme...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

NCT ID: NCT05794477

This clinical trial is studying a new treatment combination of two drugs, SHR-1802 and adebrelimab, for patients with advanced solid tumors, which are types of cancer that form in solid organs like...

Recruiting

Phase: PHASE1 Type: interventional Locations: Changsha, Hunan, China

The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors

NCT ID: NCT05836948

This clinical trial is studying a new treatment called SHR-9839 for patients with advanced solid tumors, which are types of cancer that cannot be surgically removed and have either come back after ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

A Study of IMC008 for Advanced Solid Tumors

NCT ID: NCT05837299

This clinical trial is studying a new treatment called IMC008 for patients with advanced solid tumors, specifically those that test positive for a protein called CLDN18.2. The trial aims to underst...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

NCT ID: NCT05204862

This clinical trial is studying a new treatment called TU2218 for patients with advanced solid tumors, which are types of cancer that form in tissues like organs and muscles. The trial has two part...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions